These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1931443)

  • 1. Biological response modifiers.
    Clark JW
    Cancer Chemother Biol Response Modif; 1991; 12():193-212. PubMed ID: 1931443
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological monitoring and clinical trials of biological response modifiers.
    Baseler MW; Urba WJ
    Cancer Chemother Biol Response Modif; 1991; 12():231-50. PubMed ID: 1931445
    [No Abstract]   [Full Text] [Related]  

  • 3. The rational development of biological response modifiers.
    Talmadge JE
    Biotherapy; 1992; 4(3):177-8. PubMed ID: 1599800
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunological monitoring and clinical trials of biological response modifiers.
    Baseler MW; Kopp WC; Urba WJ
    Cancer Chemother Biol Response Modif; 1993; 14():249-83. PubMed ID: 7508729
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of likopid--an immunomodulator in the combined treatment of patients with endometrial adenocarcinoma].
    Venediktova MG; Rumiantseva NK; Fedorova GV; Demidova MA; Zhilenko MI
    Vopr Onkol; 2001; 47(4):481-4. PubMed ID: 11710296
    [No Abstract]   [Full Text] [Related]  

  • 6. Approaches to cancer therapy using biological response modifiers.
    MacEwen EG
    Vet Clin North Am Small Anim Pract; 1985 May; 15(3):667-88. PubMed ID: 2409659
    [No Abstract]   [Full Text] [Related]  

  • 7. Biologic response modifiers in pediatric cancer.
    Worth LL; Jeha SS; Kleinerman ES
    Hematol Oncol Clin North Am; 2001 Aug; 15(4):723-40, ix. PubMed ID: 11676281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A note on the failure of CGP 19835 A (MTP-PE) to influence the course of influenza A2 infection in human volunteers.
    Higgins PG; Barrow GI; Galbraith AW; Frost H; Tyrrell DA
    Antiviral Res; 1989 Aug; 12(1):49-52. PubMed ID: 2596839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selective antiviral and immunomodulating therapy for herpetic keratitis].
    Maĭchuk IuF
    Klin Med (Mosk); 2001; 79(9):70-1. PubMed ID: 11641944
    [No Abstract]   [Full Text] [Related]  

  • 10. Biological response modifiers in cancer therapeutics: potentialities and limitations.
    Mihich E
    Cancer Detect Prev; 1988; 12(1-6):531-5. PubMed ID: 3052839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human monocytes activated by immunomodulators in liposomes lyse herpesvirus-infected but not normal cells.
    Koff WC; Fidler IJ; Showalter SD; Chakrabarty MK; Hampar B; Ceccorulli LM; Kleinerman ES
    Science; 1984 Jun; 224(4652):1007-9. PubMed ID: 6426057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Theoretical problems of use of an immunomodulator likopid in clinical practice].
    Andronova TM; Chumakova MM
    Ter Arkh; 2002; 74(1):70-2. PubMed ID: 11878067
    [No Abstract]   [Full Text] [Related]  

  • 13. New kinds of treatment.
    AIDS Treat News; 2001 Jan; (377):4-5. PubMed ID: 11862809
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mechanism of action and clinical effectiveness of immunomodulator glucosaminylmuramyl dipeptide (licopide)].
    Ivanov VT; Andronova TM; Nesmeianov VA; Pinegin BV; Ledger P; Bomford R; Khaitov RM
    Klin Med (Mosk); 1997; 75(3):11-5. PubMed ID: 9229604
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-stress activity in a muramyl-dipeptide.
    Singh N; Jain RK; Gupta CM; Anand N
    Indian J Exp Biol; 1990 Jul; 28(7):686-7. PubMed ID: 2272655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of macrophage-augmenting factors encapsulated in liposomes for destruction of tumor metastases.
    Schroit AJ; Fidler IJ
    Prog Clin Biol Res; 1982; 102 pt A():347-55. PubMed ID: 7167445
    [No Abstract]   [Full Text] [Related]  

  • 17. GMDP for psoriasis.
    Williamson D; Chawla M; Marks R
    Lancet; 1998 Aug; 352(9127):545. PubMed ID: 9716065
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of immunomodulators on postirradiation recovery in the thymus.
    Macková NO; Fedorocko P
    Physiol Res; 1997; 46(3):193-7. PubMed ID: 9728506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of the cytokine inducer romurtide: experimental studies and clinical application.
    Azuma I
    Trends Pharmacol Sci; 1992 Dec; 13(12):425-8. PubMed ID: 1293866
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune boosters. Murabutide--debut of a new immune booster?
    TreatmentUpdate; 2003; 15(4):3. PubMed ID: 17216851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.